Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
PrEP campaigns must include youth, communities of color

Sandy Close, moderating a panel on how to close the information gap on PrEP in underserved communities, called it a “break the silence issue,” referring to the stigma and misconceptions about PrEP and HIV. Misinformation about the drug is all too rampant. Too many from communities of color believe the drug is not for them.

Published
13 hours ago
From
San Francisco Examiner
New Zealand AIDS Foundation welcomes PHARMAC’s milestone proposal to fund Pre-exposure Prophylaxis (PrEP)

In a proposal released today, PHARMAC has announced its intention to fund the HIV-prevention drug PrEP – meaning the medicine is one step closer to becoming available to those at highest risk of HIV in New Zealand.

Published
14 November 2017
From
New Zealand AIDS Foundation
British Columbia just lost its last two excuses not to cover the pill that prevents HIV

Julio Montaner, the head of the BC Centre for Excellence in HIV/AIDS, told a room full of doctors and activists Nov 6, 2017, that his centre has negotiated a deal with generic drug manufacturers that could deliver the treatment without swelling the budget. “The message is, we’re ready,” Montaner told Xtra following his announcement. “It’s time to do this.”

Published
13 November 2017
From
XTRA, Vancouver
Up to a quarter of HIV-negative gay men attending three English clinics used PrEP in the last year

A prospective cohort study of gay men attending three clinics in southern England – 56 Dean Street and Mortimer Market Centre in London and the Brighton &

Published
13 November 2017
By
Gus Cairns
Danish court invalidates Gilead SPC

The Danish Maritime and Commercial High Court has invalidated a supplementary protection certificate (SPC) owned by Gilead. On October 26, the court rejected Gilead’s motion for an injunction against generics maker Accord.

Published
10 November 2017
From
Life Sciences Intellectual Property Review
Ireland’s first clinic monitoring anti-HIV drug PrEP opens

The clinic will be open to users of the drug and will provide HIV tests and STI screening; it will not supply the drug.

Published
10 November 2017
From
The Irish Times
Gilead loss of generic HIV drug battle a boost for gay community

Published
09 November 2017
From
The Irish Times
High HIV incidence from non-primary partners and low PEP and PrEP use seen in PARTNER study

HIV incidence among the HIV-negative gay men in the PARTNER 1 and 2 studies, due to sex with partners outside the main relationship, was high,

Published
08 November 2017
By
Gus Cairns
The future of PrEP in Australia

PrEP has been a major discussion point in the 2017 ASHM conference. In a joint symposium with the 2017 Sexual Health Conference, multiple speakers spoke of the rollout of PrEP in Australia and New Zealand.

Published
08 November 2017
From
Australian Society for HIV Medicine Report Back
PrEP and reaching people of color, trans women, and young people

Not everyone at risk for HIV knows about PrEP, and many people who could benefit from PrEP believe it’s not for them. A recent panel discussion in San Francisco explored this issue. Speaking about their work and the diverse communities they serve, the panelists shared some of the important barriers that people of color, trans women and young people face related to PrEP knowledge, access and adherence.

Published
08 November 2017
From
BETA blog
← First12345...126Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.